SMTL ID : 5imx.1

Anaplastic lymphoma kinase (ALK) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-4-amino pyrimidine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

1 x CZ4: 5-chloro-N~2~-{5-methyl-4-(1-methylpiperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N~4~-{1-methyl-3-[(propan-2-yl)sulfonyl]-1H-pyrazol-4-yl}pyrimidine-2,4-diamine(Non-covalent)

CZ4.1: 20 residues within 4Å: Chain A: L.38, G.39, H.40, G.41, A.42, V.46, A.64, K.66, L.112, E.113, L.114, M.115, A.116, G.118, D.119, S.122, R.169, N.170, L.172, D.186 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.38, A:D.119 Hydrogen bonds: A:M.115, A:M.115 Salt bridges: A:E.126

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, P. et al., Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-05-04

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence